Full-Time

Respiratory Therapist

Posted on 8/18/2026

Mass General Brigham

Mass General Brigham

1-10 employees

Early-stage life science venture investor

Compensation Overview

$41.81 - $50.25/hr

+ $15,000 sign-on bonus

Boston, MA, USA

In Person

Bachelor's, Associate's

Category
Medical, Clinical & Veterinary (1)
Required Skills
CPR

Get referred to Mass General Brigham

See people who can refer or advise you

Requirements
  • An Associate of Science degree in Respiratory Therapy is required.
  • One year of clinical training or equivalent is required.
  • Current licensure as a Respiratory Therapist by the Commonwealth of Massachusetts is required.
  • Registration as a Registered Respiratory Therapist by the National Board for Respiratory Care is required within six months of hire.
  • Excellent interpersonal skills are required to interact with physicians, nurses, and other allied health care members.
  • Strong patient assessment skills are required.
  • Professional and technical skills are required to act as a staff therapist.
  • The ability to motivate and direct professional and technical staff is required.
  • Knowledge of growth and development from adolescent through geriatric patients is required.
  • The ability to assess patient-related data relative to age-specific needs and provide care according to department policies and procedures is required.
  • Continuing education related to age-specific care and cultural diversity is required.
  • The role requires working in patient-care environments including intensive care, recovery room, and emergency room, with exposure to communicable diseases and secretions or excretions and possible prolonged standing during emergencies.
Responsibilities
  • Provide professional respiratory care, including initiating and maintaining mechanical ventilation, assisting with insertion, stabilization, and maintenance of artificial airways, and administering respiratory care modalities.
  • Use professional judgment to determine the appropriateness of therapy, modify treatment, and notify physicians with recommendations for changes.
  • Administer and interpret pulse oximetry, pulmonary mechanics, pulmonary function testing, airway-clearance techniques, and alveolar gas measurements to evaluate therapy.
  • Respond to respiratory emergencies, including cardiopulmonary resuscitations, and establish and maintain patient airways.
  • Transport and maintain mechanically ventilated patients.
  • Assess patient condition using medical history, observation, examination, physician diagnosis, laboratory findings, and respiratory tests and procedures.
  • Work collaboratively with the care team based on patient assessments.
  • Make regular rounds and administer respiratory care modalities to assigned patients.
  • Observe and evaluate patient condition, progress, and response to treatment, and contribute to the care plan accordingly.
  • Complete documentation of patient-care observations, treatments administered, patient responses, and reports to the Respiratory Care Clinical Supervisor and physicians.
  • Instruct respiratory technicians and students in respiratory care procedures.
  • Educate students, physicians, staff, patients, and family members about respiratory techniques.
  • Clinically supervise respiratory therapy students in patient-care areas.
  • Attend educational meetings, patient-care reports, staff meetings, and conferences, and maintain continuing education.
  • Assist with departmental research projects.
Desired Qualifications
  • A Bachelor of Science degree in Respiratory Therapy is preferred.
  • Two years of previous critical care experience is preferred.
  • Experience with extracorporeal membrane oxygenation is strongly preferred.

Mass General Brigham Ventures funds early-stage life science ideas arising from Mass General Brigham’s research network. It provides first access to deal flow and proprietary rights, backing the formation and growth of new companies and technologies. It uses capital and support to help translate bold innovations into drugs and medical technologies that improve patient outcomes worldwide.

Company Size

1-10

Company Stage

N/A

Total Funding

$1.9B

Headquarters

Cambridge, Massachusetts

Founded

2008

Get referred to Mass General Brigham

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Fiscal 2025 operating income reached $59 million after a $53 million reorganization charge.
  • Mead Johnson expanded a five-year research partnership with MGB in April 2026.
  • MGB bridge funding keeps NIH-dependent researchers alive through August 2026 deadlines.

What critics are saying

  • Brigham nurses struck July 2026 after a five-day lockout over wages and insurance.
  • MGB closed the Weiner Center, Burn Unit, and iCMP, angering clinicians.
  • Repeated labor conflict and service cuts threaten talent retention and patient trust.

What makes Mass General Brigham unique

  • Mass General Brigham runs nearly $2 billion in research and 3,700 trials.
  • Its 2026 MIT seed program linked 17 translational teams across engineering and care.
  • MGB controls first-look access to discoveries from Harvard-affiliated hospitals and investigators.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Flexible Work Hours

Remote Work Options

Hybrid Work Options

Paid Vacation

Paid Sick Leave

Paid Holidays

Family Planning Benefits

Fertility Treatment Support

Professional Development Budget

Conference Attendance Budget

Wellness Program

Mental Health Support

Gym Membership

Phone/Internet Stipend

Home Office Stipend

Stock Options

Company Equity

401(k) Company Match

Parental Leave

Adoption Assistance

Childcare Support

Relocation Assistance

Employee Referral Bonus

Tuition Reimbursement

Professional Certification Support

Mentorship Program

Meal Benefits

Commuter Benefits

Legal Services

Employee Discounts

Company Social Events

Company News

Claris Bio
Jul 29th, 2026
07-28-2026 Press Releases from Claris Bio

Latest Press Releases from Claris Bio.

Fierce Healthcare
Jun 15th, 2026
InStride Health lands $30M series C to expand pediatric mental health services

InStride Health, a provider of virtual specialty mental healthcare for children and young adults, has raised $30 million in Series C funding led by Echo Health Ventures and FMZ Ventures. Existing investors including .406 Ventures, General Catalyst and Mass General Brigham Ventures also participated. Founded in 2021, InStride offers insurance-based treatment for anxiety and obsessive-compulsive disorder in patients aged seven to 24. The company pairs each patient with a care team comprising a psychiatrist, therapist and exposure coach, providing support through text and a mobile application. InStride has treated 5,000 patients across 17 states, primarily on the East Coast and Texas. The company published data showing 97% of patients demonstrated clinical improvement, with a 53% average reduction in anxiety scores. The funding will support expansion into new markets and strengthen payer partnerships.

Associated Press
May 13th, 2026
Violet Therapeutics raises $4.75M to advance synaptic preservation therapy for neurodegenerative diseases

Violet Therapeutics, a biotechnology company developing therapies for neurodegenerative diseases, has raised $4.75 million in a seed extension round led by Lifespan Vision Ventures. Dementia Discovery Fund, UTEC, Ono Venture Investment and Mass General Brigham Ventures also participated. The Cambridge-based company will use the funding to advance its lead small molecule programme targeting EphB3 through IND-enabling activities. The therapy aims to halt and potentially reverse cognitive decline through glial-mediated synaptic preservation, addressing synaptic loss, the strongest predictor of cognitive decline in Alzheimer's and other neurodegenerative diseases. Violet's proprietary CONNECT platform maps cell-cell interaction networks to identify novel therapeutic targets. Founded by Mass General Brigham Ventures with researchers from Brigham and Women's Hospital, the company is developing first-in-class CNS therapies.

PR Newswire
Apr 23rd, 2026
Brigham nurses to picket as MGB executives earn $35.9M amid service closures and 0% wage offer

Registered nurses at Brigham and Women's Hospital will hold an informational picket on 29 April, protesting Mass General Brigham's corporate decisions affecting patient care and workforce conditions. The Massachusetts Nurses Association represents the nurses, who will demonstrate from 14:00 to 16:00 outside the hospital at 75 Francis Street, Boston. Nurses cite several service closures under MGB, including the Weiner Centre, Burn Unit and Integrated Care Management Programme. They criticise the health system's bargaining proposals, particularly a 0% wage offer for nurses below top step, whilst MGB reported a $59.2 million operating gain in 2025 and paid its top 14 executives $35.9 million in fiscal year 2024. The informational picket will not disrupt patient care, with nurses participating outside working hours.

PR Newswire
Mar 19th, 2026
MGB Home Care clinicians to picket Mass General over stalled contract talks after year of bargaining

Approximately 450 clinicians at Mass General Brigham Home Care, represented by the Massachusetts Nurses Association, will hold an informational picket on 24 March outside Massachusetts General Hospital. The clinicians are seeking their first union contract after more than 20 bargaining sessions since March 2025. The bargaining unit includes registered nurses, occupational therapists, physical therapists, speech language pathologists, social workers and dieticians who voted to join the MNA in June 2024. They are demanding reasonable caseload limits, clear productivity standards, competitive wages and recruitment protections. MGB reported a $59.2 million operating gain in the year ending September 2025, with CEO Dr Anne Klibanski's compensation rising 40% to $8.4 million in 2024. The picket is scheduled for 15:30 to 17:00 and is not a strike.